Caliway Biopharmaceuticals Co., Ltd. (6919.TWO)
TWD 571.0
(-2.89%)
TWD 571.0
(-2.89%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 38.93 Million | 12.82 Million | 12.33 Million | 10.35 Million | 18.65 Million |
| Cost of Revenue | 11.46 Million | 3.21 Million | 3.1 Million | 3.67 Million | 7.84 Million |
| Gross Profit | 27.46 Million | 9.6 Million | 9.23 Million | 6.67 Million | 10.8 Million |
| Operating Expenses | 540.93 Million | 329.23 Million | 239.96 Million | 112.27 Million | -122.13 Million |
| Selling, General and Administrative Expenses | 36.94 Million | 34.21 Million | 59.34 Million | 23.29 Million | 23.8 Million |
| Research and Development Expenses | 503.99 Million | 295.01 Million | 180.61 Million | 88.98 Million | 109.14 Million |
| Other Expenses | 8.09 Million | 28.94 Million | 9.27 Million | 11.67 Million | -122.13 Million |
| Cost and Expenses | 552.4 Million | 332.44 Million | 243.07 Million | 115.95 Million | -122.13 Million |
| Operating Income | -487.95 Million | -285.48 Million | -221.36 Million | -105.6 Million | -122.13 Million |
| Interest Expense | 498 Thousand | 668 Thousand | 2.9 Million | 4.5 Million | 3.69 Million |
| Income Tax Expense | - | - | 30 Thousand | 86 Thousand | 31 Thousand |
| Earnings before Tax | -488.45 Million | -286.15 Million | -224.26 Million | -98.4 Million | -121.8 Million |
| Net Income | -488.45 Million | -286.15 Million | -224.29 Million | -98.48 Million | -121.83 Million |
| Earnings Per Share Basic | -3.94 | -2.44 | -4.87 | -1.85 | -2.28 |
| Earnings Per Share Diluted | -3.94 | -2.44 | -4.87 | -1.85 | -2.28 |
| Weighted Average Shares Outstanding | 123.88 Million | 117.12 Million | 46.07 Million | 53.35 Million | 53.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 123.88 Million | 117.12 Million | 46.07 Million | 53.35 Million | 53.35 Million |
| Gross Margin | 0.71 | 0.75 | 0.75 | 0.64 | 0.58 |
| EBIT Margin | -11.82 | -20.29 | -16.05 | -7.31 | -6.55 |
| Profit Margin | -12.55 | -22.32 | -18.18 | -9.52 | -6.53 |
| EBITDA | -460.09 Million | -260.15 Million | -198.08 Million | -94.42 Million | -106.69 Million |
| Earnings Before Tax Margin | -12.53 | -22.27 | -17.94 | -10.20 | -6.55 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 7.84 Million | 3.96 Million | 11.85 Million | 38.93 Million | 11.85 Million | 11.52 Million |
| Cost of Revenue | 2.59 Million | 1.31 Million | 3.22 Million | 11.46 Million | 3.22 Million | 3.78 Million |
| Gross Profit | 5.25 Million | 2.65 Million | 8.62 Million | 27.46 Million | 8.62 Million | 7.74 Million |
| Operating Expenses | 199.8 Million | 243.59 Million | 126.5 Million | 540.93 Million | 126.5 Million | 184.48 Million |
| Selling, General and Administrative Expenses | 24.4 Million | 11.22 Million | 10.25 Million | - | 10.25 Million | 7.02 Million |
| Research and Development Expenses | 175.4 Million | 232.36 Million | 118.05 Million | - | 118.05 Million | 177.45 Million |
| Other Expenses | 3.57 Million | 17.79 Million | - | 8.09 Million | - | 5.76 Million |
| Cost and Expenses | 202.39 Million | 244.91 Million | 129.72 Million | 552.4 Million | 129.72 Million | 188.26 Million |
| Operating Income | -194.55 Million | -218.37 Million | -119.68 Million | -487.95 Million | -119.68 Million | -165.86 Million |
| Interest Expense | 89 Thousand | 98 Thousand | - | 498 Thousand | - | 130 Thousand |
| Income Tax Expense | 17.99 Million | - | - | - | - | - |
| Earnings before Tax | -176.65 Million | -218.47 Million | -113.65 Million | -488.45 Million | -113.65 Million | -165.99 Million |
| Net Income | -176.65 Million | -218.47 Million | -113.65 Million | -488.45 Million | -113.65 Million | -165.99 Million |
| Earnings Per Share Basic | -1.27 | -1.57 | -0.91 | - | -0.91 | -1.34 |
| Earnings Per Share Diluted | -1.27 | -1.57 | -0.91 | - | -0.91 | -1.34 |
| Weighted Average Shares Outstanding | 139.09 Million | 139.35 Million | 124.68 Million | 123.88 Million | 124.68 Million | 123.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 139.09 Million | 139.35 Million | 124.68 Million | 123.88 Million | 124.68 Million | 123.88 Million |
| Gross Margin | 0.67 | 0.67 | 0.73 | 0.71 | 0.73 | 0.67 |
| EBIT Margin | -21.57 | -53.24 | -9.67 | - | -9.67 | -13.79 |
| Profit Margin | -22.51 | -55.09 | -9.59 | -12.55 | -9.59 | -14.40 |
| EBITDA | -169.31 Million | -211.15 Million | -114.61 Million | - | -114.61 Million | -159.01 Million |
| Earnings Before Tax Margin | -24.79 | -55.06 | -10.10 | -12.53 | -10.10 | -14.39 |
NVA
SUN
APGO
RF-PE
WCN
HOVE